Showing results (81-90 of 248) with videos related to

Sort By:
Pageof 25
Vaccine|January 19, 2026
Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in EnglandAryan Nikhab, Tara Patel, Graeme Rooney, et al.
Vaccines|August 26, 2022
Cross-Sectional Study of University Students' Attitudes to 'On Campus' Delivery of COVID-19, MenACWY and MMR Vaccines and Future-Proofing Vaccine Roll-Out StrategiesAdam Webb, Mayuri Gogoi, Sarah Weidman, et al.
The Journal of Infection|November 13, 2019
Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in EnglandHelen Campbell, Nick Andrews, Sydel Parikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2025
Clinical and Microbiological Characteristics of Meningococcal Eye Infections: Retrospective National Surveillance in England, 2010-2022Stephen A Clark, Emma Heymer, Helen Campbell, et al.
Vaccine|April 28, 2018
Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015Sydel R Parikh, Helen Campbell, Stephen J Gray, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?Alison Kent, Ashley Makwana, Carmen L Sheppard, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 4, 2025
Impact of molecular point-of-care testing on surveillance and public health management of invasive meningococcal diseaseEmma J Heymer, Stephen A Clark, Helen Campbell, et al.
Archives of Disease in Childhood|February 21, 2014
Very low rates of culture-confirmed invasive bacterial infections in a prospective 3-year population-based surveillance in Southwest LondonKirsty Le Doare, Anna-Louise Nichols, Helen Payne, et al.
The Lancet. Infectious Diseases|February 4, 2024
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance studyMarta Bertran, Joshua C D'Aeth, Fariyo Abdullahi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2018
Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014Godwin Oligbu, Sarah Collins, Nick Andrews, et al.
Pageof 25